Sex hormones: a role in the control of multiple sclerosis? (Q31037759)

28 June 2017

1 reference

title

Sex hormones: a role in the control of multiple sclerosis? (English)

1 reference

28 June 2017

0 references

1

Valentina Tomassini

1 reference

28 June 2017

Carlo Pozzilli

2

1 reference

28 June 2017

language of work or name

English

0 references

publication date

1 May 2006

1 reference

Expert Opinion on Pharmacotherapy

28 June 2017

published in

1 reference

28 June 2017

volume

7

1 reference

28 June 2017

issue

7

1 reference

28 June 2017

page(s)

857-868

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.857

28 June 2017

1 reference

Microchimerism: an investigative frontier in autoimmunity and transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.857

Prognostic factors in a multiple sclerosis incidence cohort with twenty-five years of follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.857

Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.857

'Gender gap' in multiple sclerosis: magnetic resonance imaging evidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.857

Estrogen improves biochemical and neurologic outcome following traumatic brain injury in male rats, but not in females

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.857

Sex hormones modulate brain damage in multiple sclerosis: MRI evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.857

Sexual dimorphism and asymmetries in the gray–white composition of the human cerebrum

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.857

Testosterone increases and estradiol decreases middle cerebral artery occlusion lesion size in male rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.857

Linkage disequilibrium analysis of chromosome 12q14-15 in multiple sclerosis: delineation of a 118-kb interval around interferon-gamma (IFNG) that is involved in male versus female differential susceptibility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.857

Increased immunoreactivity to two overlapping peptides of myelin proteolipid protein in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.857

The genetics of multiple sclerosis: principles, background and updated results of the United Kingdom systematic genome screen

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.857

Multiple sclerosis in sibling pairs: an analysis of 250 families

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.857

Twin concordance and sibling recurrence rates in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.857

Evidence for genetic basis of multiple sclerosis. The Canadian Collaborative Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.857

Sex hormones and glucocorticoids: interactions with the immune system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.857

Effects of the menstrual cycle on medical disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.857

Estrogen modulation of K(+) channel activity in hypothalamic neurons involved in the control of the reproductive axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.857

Pregnancy, delivery, and birth outcome in women with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.857

Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.857

Steroid hormones in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.857

Magnetic resonance evaluation of disease activity during pregnancy in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.857

Pregnancy and the susceptibility of Lewis rats to experimental allergic encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.857

Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.857

An insight into the dendritic cells at the maternal-fetal interface.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.857

Preliminary studies of cytokine secretion patterns associated with pregnancy in MS patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.857

Effects of sex hormones on costimulatory molecule expression in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.857

Homeostatic control of immunity by TCR peptide-specific Tregs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.857

Pregnancy is associated with a lower risk of onset and a better prognosis in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.857

Infant health of mothers with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.857

Recent use of oral contraceptives and the risk of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.857

The natural history of multiple sclerosis: a geographically based study. 5. The clinical features and natural history of primary progressive multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.857

Sex steroid regulation of microglial cell activation: relevance to multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.857

Gonadal hormones influence the immune response to PLP 139-151 and the clinical course of relapsing experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.857

Estriol ameliorates autoimmune demyelinating disease: implications for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.857

A synthetic androstene derivative and a natural androstene metabolite inhibit relapsing-remitting EAE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.857

Androgens indirectly accelerate thymocyte apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.857

Testosterone amplifies excitotoxic damage of cultured oligodendrocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.857

Estrogen inhibition of EAE involves effects on dendritic cell function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.857

Estrogen inhibits systemic T cell expression of TNF-alpha and recruitment of TNF-alpha(+) T cells and macrophages into the CNS of mice developing experimental encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.857

Estrogen potentiates treatment with T-cell receptor protein of female mice with experimental encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.857

Neuroimmunoprotective effects of estrogen and derivatives in experimental autoimmune encephalomyelitis: therapeutic implications for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.857

Novel mechanisms of estrogen action in the brain: new players in an old story.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.857

ER beta: identification and characterization of a novel human estrogen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.857

Differential regulation and action of estrogen receptors alpha and beta in GH3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.857

Estrogen receptor (ER) modulators each induce distinct conformational changes in ER alpha and ER beta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.857

Treatment of multiple sclerosis with the pregnancy hormone estriol

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.857

Divergent effects of ovarian steroids on neuronal survival during experimental allergic encephalitis in Lewis rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.857

Early pregnancy factor has immunosuppressive and growth factor properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.857

Early pregnancy factor treatment suppresses the inflammatory response and adhesion molecule expression in the spinal cord of SJL/J mice with experimental autoimmune encephalomyelitis and the delayed-type hypersensitivity reaction to trinitrochlorobe

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.857

Alpha-fetoprotein Suppresses Experimental allergic Encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.857

Experimental allergic encephalomyelitis in the guinea pig. Failure to suppress with crude human chorionic gonadotrophin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.857

Leptin and the regulation of body weight in mammals

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.857

Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.857

The use of mitoxantrone (Novantrone) for the treatment of multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.857

Multiple sclerosis gender issues: clinical practices of women neurologists

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.857

Pregnancy and multiple sclerosis (the PRIMS study): clinical predictors of post‐partum relapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.857

A full genome search in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.857

Parent-of-origin effect in multiple sclerosis: observations in half-siblings

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.857

Early pregnancy factor suppresses experimental autoimmune encephalomyelitis induced in Lewis rats with myelin basic protein and in SJL/J mice with myelin proteolipid protein peptide 139-151

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.857

Sex differences in cytokine responses to myelin peptides in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.857

Sex and age at diagnosis are correlated with the HLA-DR2, DQ6 haplotype in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.857

Gender does not influence the susceptibility of C57BL/6 mice to develop chronic experimental autoimmune encephalomyelitis induced by myelin oligodendrocyte glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.857

Lack of association between estrogen receptor 1 gene polymorphisms and multiple sclerosis in southern Italy in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.857

IFNG polymorphisms are associated with gender differences in susceptibility to multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.857

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.857

The premenstrual period and exacerbations in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.857

Control of immune pathology by regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.857

Risk of Multiple Sclerosis Exacerbation During Pregnancy and Breast-feeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.857

Gender differences in protection from EAE induced by oral tolerance with a peptide analogue of MBP-Ac1-11

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.857

Estradiol binding to cell surface raises cytosolic free calcium in T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.857

Corticosteroid treatment of experimental autoimmune encephalomyelitis in the Lewis rat results in loss of Vβ8.2+ and myelin basic protein-reactive cells from the spinal cord, with increased total T-cell apoptosis but reduced apoptosis of Vβ8.2+ cel

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.857

Leptin as a marker of multiple sclerosis activity in patients treated with interferon-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.857

Randomized controlled trial of interferon- beta-1a in secondary progressive MS: Clinical results

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.857

The PROMiSe trial: baseline data review and progress report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.857

Effect of intravenous immunoglobulin treatment on pregnancy and postpartum-related relapses in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.857

Intravenous corticosteroids in the postpartum period for reduction of acute exacerbations in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.7.857

21 January 2018

Identifiers

DOI

10.1517/14656566.7.7.857

1 reference

28 June 2017

1 reference